Press Releases

  • VolitionRx Limited to Ring the New York Stock Exchange Closing Bell on Monday, March 13th at 4 pm Eastern Daylight Time

  • VolitionRx Limited Announces Full Fiscal Year 2016 Financial Results and Business Update

  • VolitionRx Limited to Present at the 29th Annual ROTH Conference

  • VolitionRx Limited Schedules Fourth Quarter and Full Year 2016 Earnings Conference Call and Business Update

  • A Logistics and Pathway Design Study for Volition's CE Marked NuQ(TM) Triage Test has been Commenced in the Capital Region of Denmark

  • VolitionRx Limited's Triage Test Results Validated in Prospective Trial

  • VolitionRx Limited to Attend the BTIG 2017 Medical Technology, Life Sciences, and Diagnostics Conference

  • VolitionRx Limited to Present at Source Capital Group's 2nd Annual Disruptive Growth & Healthcare Conference on February 15, 2017

  • VolitionRx Limited Strengthens Team with Key Appointment to Drive Sales and Trials in Asia

  • VolitionRx Limited's Novel Cancer Diagnostic Test Achieves CE Marking as it Prepares for Launch Across Europe

arrow-down arrow-left arrow-right arrow chevron-down circle-link--red circle-link close play plus